Compare TNC & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNC | PRCT |
|---|---|---|
| Founded | 1870 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.2B |
| IPO Year | 1994 | 2021 |
| Metric | TNC | PRCT |
|---|---|---|
| Price | $68.65 | $17.22 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 11 |
| Target Price | ★ $79.00 | $35.44 |
| AVG Volume (30 Days) | 143.5K | ★ 1.2M |
| Earning Date | 05-04-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | N/A | ★ 1.71 |
| EPS | ★ 0.45 | N/A |
| Revenue | ★ $1,137,600,000.00 | $308,054,000.00 |
| Revenue This Year | $5.77 | $31.34 |
| Revenue Next Year | $4.95 | $24.52 |
| P/E Ratio | $151.58 | ★ N/A |
| Revenue Growth | N/A | ★ 37.22 |
| 52 Week Low | $60.18 | $16.67 |
| 52 Week High | $91.93 | $38.11 |
| Indicator | TNC | PRCT |
|---|---|---|
| Relative Strength Index (RSI) | 44.07 | 32.43 |
| Support Level | $64.88 | $16.89 |
| Resistance Level | $88.96 | $29.12 |
| Average True Range (ATR) | 2.03 | 0.86 |
| MACD | 0.24 | -0.35 |
| Stochastic Oscillator | 34.55 | 6.17 |
Tennant Co is engaged in designing, manufacturing and marketing solutions that empower customers to achieve quality cleaning performance, reduce environmental impact and help create a cleaner, safer, healthier world. The Company is committed to creating and commercializing breakthrough, sustainable cleaning innovations to enhance its broad suite of products, including floor maintenance and cleaning equipment, detergent-free and other sustainable cleaning technologies, aftermarket parts and consumables, equipment maintenance and repair service, and asset management solutions. Its products are used in many types of environments, including retail establishments, distribution centers, factories and warehouses, public venues such as arenas and stadiums, office buildings, schools, and more.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.